The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 1980

Filed:

Aug. 03, 1978
Applicant:
Inventors:

Aake N Joensson, Solna, SE;

Ferenc Merenyi, Taeby, SE;

Pinchas Moses, Saltsjoe-Boo, SE;

Lennart E Karlsson, Vaellingby, SE;

Gunnar Hanshoff, Jaerfaella, SE;

Assignee:

AB Kabi, Stockholm, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C / ; C07C / ; A61K / ; A61K / ;
U.S. Cl.
CPC ...
424321 ; 2605 / ; 2605 / ; 2605 / ; 2603 / ; 424228 ;
Abstract

New compounds of the general formula I ##STR1## wherein R.sup.1 and R.sup.2 each independently represent an alkyl group containing 1 to 4 carbon atoms, or an alkoxy group containing 1 to 3 carbon atoms, or halogen, R.sup.3 represents hydrogen, halogen, an alkyl group containing 1 to 4 carbon atoms, an alkoxy group containing 1 to 3 carbon atoms, an amino group or a nitro group, A represents ##STR2## which is bonded to the benzene ring by its sulphur or nitrogen atom and in which R.sup.4 is hydrogen or an alkyl group containing 1 to 4 carbon atoms; together with salts thereof with physiologically acceptable acids and, when R.sup.4 is hydrogen, with physiologically acceptable bases are described. The compounds are of use in inhibiting thrombosis formation, in treating thrombosis and in fibronolytic therapy. Various methods of producing the new compounds are described involving the building up of the --A--CH.sub.2 --CH.sub.2 --S--CH.sub.2 CH.sub.2 NH.sub.2 side chain from aromatic precursors having an incomplete side chain or by introducing at least one of the R.sup.1, R.sup.2 or R.sup.3 substituents into a precursor lacking that substituent or from an amino-protected precursor.


Find Patent Forward Citations

Loading…